Design Therapeutics (DSGN) Other financing activities (2021 - 2026)

Design Therapeutics has reported Other financing activities for 6 years, with the latest figure at $141000.0 in Q2 2026.

• Other financing activities for Q2 2026 came in at $141000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2026 was $387000.0 (up 1072.73% YoY), and the FY2025 annual result was $242000.0, up 572.22% from the prior year.
• Other financing activities advanced to $141000.0 in Q2 2026, from $27000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $402000.0 in Q4 2023 and troughed at $1000.0 in Q3 2024.
• A 5-year average of $84571.4 and a median of $25000.0 in 2025 frame the typical range for Other financing activities.
• The widest annual swing landed in 2022, when Other financing activities slumped 99.94%; it then soared 3600.0% in 2025.
• A 5-year view of Other financing activities shows it stood at $16000.0 in 2022, then surged by 2412.5% to $402000.0 in 2023, then tumbled by 97.76% to $9000.0 in 2024, then jumped by 1922.22% to $182000.0 in 2025, then declined by 22.53% to $141000.0 in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $141000.0 in Q2 2026, $27000.0 in Q1 2026, and $182000.0 in Q4 2025.